Protein Language Models in Bioinformatics: A Practical Guide to Selection and Application
Protein language models (PLMs) have become standard tools in bioinformatics for representing amino acid sequences as numerical embeddings that capture evolutionary, structural, and functional information. This article provides a decision framework for selecting among popular PLMs such as ESM2, ProtT5, and Ankh based on task type, computational resources, and published performance benchmarks. It includes a comparison table, implementation guidance, and practical steps for integrating PLMs into research workflows.
What Protein Language Models Do
Protein language models apply neural network architectures originally developed for natural language processing to biological sequences. These models are pre-trained on large collections of protein sequences, learning statistical patterns that reflect evolutionary constraints, structural preferences, and functional motifs. The resulting embeddings, which are high-dimensional numerical vectors, can serve as input features for downstream supervised methods in protein prediction tasks.
The core value of PLMs lies in their ability to condense biological information into compact representations. According to a review in Current Opinion in Structural Biology, embeddings from PLMs implicitly contain information about the grammar of protein sequences, and for many applications, MSA-free PLM-based predictions have become significantly more accurate than traditional approaches that rely on multiple sequence alignments. The review also notes that PLM-based methods tend to consume fewer computational resources than MSA-based solutions once pre-training is complete.
A systematic review of PLMs published in 2025 describes these models as a transformative force in biological research, covering model architectures, positional encoding, scaling laws, and training datasets. The review emphasizes that much of the existing literature focuses narrowly on specific domains, missing broader analysis of PLMs as a class of tools.
At a Glance: PLM Selection Decision Table
| Task Type | Recommended Model Family | Key Considerations | Example Evidence |
|---|---|---|---|
| Protein crystallization prediction | ESM2 (30 or 36 layers) | LightGBM classifiers using ESM2 embeddings outperformed other PLMs and sequence-based methods on AUPR, AUC, and F1 metrics | Benchmark study in Scientific Reports |
| Antimicrobial peptide detection | ProtT5 or ESM2 with machine learning classifiers | Sequence-based binary classification achieved average precision exceeding 83% across 21 models | AMP-Detector study in International Journal of Molecular Sciences |
| Variant effect prediction | Structure-informed PLMs | Compact models with structural context injection performed robustly across deep mutagenesis benchmarks | SI-pLM framework in Research Square |
| Protein-protein interaction prediction | Jointly encoded PLM pairs | Models that encode protein pairs together outperformed single-protein approaches on cross-species benchmarks | PLM-interact study in Nature Communications |
| Protein fitness prediction with limited data | Any PLM with few-shot learning | Meta-transfer learning and parameter-efficient fine-tuning improved performance with tens of labeled mutants | FSFP study in Nature Communications |
| Protein solubility prediction | ESM2 embeddings with structural cues | Cross-attention framework integrating ESM-2 and AlphaFold-derived features achieved AUC of 0.920 | SeqStruct-XAttn study in Computers in Biology and Medicine |
Core Principles of PLM Selection
Task Type Determines Model Choice
Different bioinformatics tasks benefit from different PLM architectures and training strategies. The relationship between task and model choice is not arbitrary. For protein crystallization prediction, a benchmark study using the TRILL platform compared LightGBM and XGBoost classifiers built on embeddings from ESM2, Ankh, ProtT5-XL, ProstT5, xTrimoPGLM, and SaProt. The classifiers using ESM2 embeddings with 30 and 36 transformer layers and 150 and 3000 million parameters achieved performance gains of 3 percent or more compared to all other models across evaluation metrics including AUPR, AUC, and F1 on independent test sets.
For antimicrobial peptide detection, a pipeline integrating PLMs with machine learning algorithms produced 21 models targeting antimicrobial, antiviral, and antibacterial activity. These models achieved average precision exceeding 83 percent and outperformed existing methods for AMPs while delivering comparable results for other biological activity types.
Computational Resources Shape Feasible Options
PLMs vary substantially in size, from models with hundreds of millions of parameters to those with billions. Larger models generally capture more information but require more memory and compute time for both inference and fine-tuning. The benchmark study on crystallization prediction found that ESM2 models with 150 and 3000 million parameters both performed well, suggesting that model size alone does not determine success for all tasks.
A transfer learning analysis that conducted 370 experiments across different downstream tasks, architectures, model sizes, model depths, and pretraining times found that while almost all downstream tasks benefit from pretrained models compared to naive sequence representations, for the majority of tasks performance does not scale with pretraining. Instead, performance often relies on low-level features learned early in pretraining. This finding points to a mismatch between current PLM pretraining paradigms and most applications, indicating that researchers should not assume larger models will automatically improve results.
Embedding Quality Depends on Alignment with Data Structure
The quality of embeddings relies heavily on how well the geometry of the embedding space aligns with the underlying data structure. A study in Genes proposed a method for designing numerical embeddings in Euclidean space for proteins by leveraging 3D structure information through contact maps. These embeddings were combined with features extracted from LLMs and traditional feature engineering techniques to enhance performance in supervised protein analysis. Experimental results on benchmark datasets including PDB Bind and STCRDAB demonstrated superior performance for protein function prediction.
This finding suggests that for tasks where 3D structure matters, combining PLM embeddings with structural information can improve results beyond what sequence-only embeddings achieve.
Practical Workflow for PLM Implementation
Step 1: Define the Task and Available Data
Before selecting a PLM, clarify the specific prediction task and the amount of labeled data available. Tasks fall into several categories:
- Sequence classification tasks such as predicting protein function, solubility, or crystallization propensity
- Variant effect prediction where the goal is to assess how mutations affect protein function
- Interaction prediction for protein-protein or drug-target relationships
- Generative tasks where the goal is to design novel protein sequences
The amount of labeled data matters because it determines whether you can fine-tune a PLM or should use embeddings with a simple downstream classifier. The FSFP study demonstrated that protein language models can be optimized under extreme data scarcity for fitness prediction using tens of labeled single-site mutants from the target protein. This approach combined meta-transfer learning, learning to rank, and parameter-efficient fine-tuning.
Step 2: Select the Model Architecture
Choose a PLM architecture based on the task type and available resources. Common options include:
- ESM2 models available in multiple sizes, with embeddings that have shown strong performance across diverse tasks including crystallization prediction and solubility prediction
- ProtT5 models that have been used for antimicrobial peptide detection and memorization studies
- Ankh and other models that offer different architectural tradeoffs
- Structure-informed PLMs that incorporate structural context during training for variant effect prediction
For protein-protein interaction prediction, the PLM-interact approach demonstrated that jointly encoding protein pairs, analogous to next-sentence prediction in natural language processing, achieves state-of-the-art performance on a cross-species benchmark. This model was trained on human data and tested on mouse, fly, worm, E. coli, and yeast, and it outperformed existing approaches in predicting virus-host interactions at the protein level.
Step 3: Prepare Input Sequences
Standardize input sequences before feeding them to a PLM. Key considerations include:
- Remove or mask non-standard amino acid characters
- Truncate or pad sequences to consistent lengths where required
- Validate sequences against reference databases such as those available through NCBI Data Resources
- Document any filtering steps applied to the input data
For tasks involving structural information, you may need to generate predicted structures using tools like AlphaFold before combining structural cues with PLM embeddings. The SeqStruct-XAttn model for E. coli protein solubility prediction integrated ESM-2 PLM embeddings with AlphaFold-derived structural cues, combining classical sequence descriptors, evolutionary profiles, PLM embeddings, and predicted structural attributes.
Step 4: Generate Embeddings
Extract embeddings from the selected PLM for each sequence in your dataset. The typical approach is to pass sequences through the model and extract the hidden representations from a chosen layer. For many tasks, averaging embeddings across all positions in a sequence produces a fixed-length representation that can be used with standard machine learning classifiers.
The TRILL platform provides a framework for using PLMs for crystallization propensity prediction, and similar frameworks exist for other tasks. When generating embeddings, record which model version and layer were used, as these choices affect the resulting representations.
Step 5: Train Downstream Models
Use the embeddings as input features for downstream supervised methods. Common choices include:
- LightGBM or XGBoost classifiers for classification tasks
- Neural network regressors for continuous predictions
- Cross-attention frameworks for tasks requiring sequence-structure integration
The AMP-Detector pipeline integrated protein language models with machine learning algorithms to train binary classification models for antimicrobial, antiviral, and antibacterial activity. The study used the Peptide Atlas to discover over 190,000 potential AMPs and demonstrated an integrative approach with generative learning for de novo design, resulting in over 500 novel AMPs.
Step 6: Evaluate and Validate
Evaluate model performance on independent test sets that were not used during training. Report standard metrics appropriate for the task:
- AUPR and AUC for classification tasks
- R-squared and RMSE for regression tasks
- F1 score for tasks with imbalanced classes
The crystallization benchmark study reported performance gains for ESM2-based classifiers across AUPR, AUC, and F1 on independent test sets. The solubility prediction study reported an R-squared of 0.560 and RMSE of 0.198 on the independent test set, with an ensemble of five models improving performance to R-squared of 0.575 and RMSE of 0.190.
Options and Tradeoffs in PLM Selection
Sequence-Only vs. Structure-Aware Models
Sequence-only PLMs are trained exclusively on amino acid sequences and capture evolutionary and functional information from sequence patterns. Structure-aware models incorporate 3D structural information either during training or at inference time.
A study in Communications Biology integrated knowledge from well-trained protein language models into several state-of-the-art geometric networks and evaluated protein representation learning benchmarks including protein-protein interface prediction, model quality assessment, protein-protein rigid-body docking, and binding affinity prediction. The findings showed an overall improvement of 20 percent over baselines, providing strong evidence that incorporating PLM knowledge enhances geometric networks capacity and can be generalized to complex tasks.
For variant effect prediction, structure-informed PLMs that inject protein structural contexts during training, without requiring structure data as model inputs at inference time, performed robustly as top performers against competing methods across deep mutagenesis scanning benchmarks. This approach extends masked sequence denoising to cross-modality denoising and is applicable to revising any sequence-only PLM.
Zero-Shot vs. Fine-Tuned Models
Zero-shot approaches use pre-trained PLMs directly without additional training on task-specific data. These approaches are attractive when labeled data is scarce. The variant effect prediction study noted that protein language models emerge as zero-shot predictors without the need for effect labels by modeling the evolutionary distribution of functional protein sequences.
Fine-tuned approaches adapt the PLM to the specific task using labeled data. The FSFP study showed that fine-tuning with tens of labeled single-site mutants can significantly boost performance for fitness prediction. The study successfully applied this approach to engineer the Phi29 DNA polymerase through wet-lab experiments, achieving a 25 percent increase in the positive rate.
Generative vs. Predictive Models
Most PLM applications are predictive, using embeddings to classify or regress protein properties. However, PLMs can also generate novel protein sequences. The crystallization benchmark study fine-tuned the ProtGPT2 model to generate crystallizable proteins. Starting with 3000 generated proteins and through filtration processes including consensus of all open PLM-based classifiers, sequence identity through CD-HIT, secondary structure compatibility, aggregation screening, homology search, and foldability evaluation, the study identified a set of 5 novel proteins as potentially crystallizable.
A study on sampling protein language models for functional protein design found that sampling strategies considering multiple mutations simultaneously significantly outperform single-mutant approaches by better capturing epistatic effects between residue pairs. The study provided practical guidance on the relative strengths of each method depending on design objectives.
Observations and Measurements for Model Assessment
Memorization vs. Generalization
A fundamental question for PLM users is whether models generalize the statistical grammar of proteins or simply memorize training data. A study using pseudoperplexity as a probe for sequence-level memorization compared ProtT5 pseudoperplexity on a pre-training proxy dataset against a post-training holdout of genuinely novel sequences. The study matched datasets by sequence length, cluster size, and taxonomic family to ensure valid comparison. ProtT5 showed a statistically significant difference in pseudoperplexity between seen and unseen sequences, though further analysis revealed this memorization signal to be modest.
For practical purposes, this means that PLM embeddings may perform better on sequences similar to those in the training data. When applying PLMs to novel protein families or synthetic sequences, expect some degradation in performance.
Performance Scaling with Model Size
The relationship between model size and downstream task performance is not straightforward. The transfer learning analysis found that for the majority of tasks, performance does not scale with pretraining and instead relies on low-level features learned early in pretraining. This finding has practical implications: researchers with limited computational resources may achieve comparable results with smaller models for many tasks.
However, the crystallization benchmark found that ESM2 models with 150 and 3000 million parameters both performed well, suggesting that for some tasks, larger models provide benefits. The choice of model size should be guided by empirical evaluation on your specific task instead of assumptions about scaling.
Cross-Species and Cross-Domain Transfer
PLMs trained on sequences from one organism or domain may transfer to other organisms with varying success. The PLM-interact study demonstrated cross-species transfer for protein-protein interaction prediction, training on human data and testing on mouse, fly, worm, E. coli, and yeast. The model outperformed existing approaches in predicting virus-host interactions.
The solubility prediction study reported that external validation on a homology-filtered Saccharomyces cerevisiae test set indicated encouraging transfer beyond E. coli, although the supervised training data remained E. coli-centric. This finding suggests that PLM-based models can generalize across organisms, but validation on your target organism is essential.
Records and Documentation for Reproducible PLM Workflows
Model Version Tracking
Record the exact model version, architecture, and parameter count for every PLM used in your workflow. Different versions of the same model family may produce different embeddings. The crystallization benchmark specified ESM2 models with 30 and 36 transformer layers and 150 and 3000 million parameters, demonstrating that version details matter for reproducibility.
Embedding Extraction Parameters
Document which layer was used for embedding extraction and whether embeddings were averaged across positions or used as position-specific features. These choices affect downstream model performance and comparability across studies.
Data Provenance
Record the source and version of all sequence data used for training and evaluation. Public databases such as NCBI Data Resources provide sequence data with versioning information. Following the FAIR Guiding Principles for data management ensures that your data and workflows are findable, accessible, interoperable, and reusable.
Computational Environment
Document the software environment including PLM library versions, PyTorch or TensorFlow versions, and hardware specifications. This information is essential for reproducing results and for troubleshooting performance issues.
Common Failure Patterns in PLM Applications
Overfitting to Training Distribution
PLMs may perform well on sequences similar to their training data but poorly on novel sequences. The memorization study found detectable but limited memorization of training data in ProtT5. When applying PLMs to sequences from underrepresented protein families or synthetic sequences, validate performance carefully.
Ignoring Structural Context
For tasks where 3D structure matters, sequence-only PLM embeddings may be insufficient. The study in Genes found that combining structural information with LLM features improved protein function prediction. The structure-informed PLM study found that biological contexts important to variant effects are implicitly modeled and effectively marginalized in sequence-only PLMs.
Inappropriate Fine-Tuning
Over-finetuning to specific family sequences can present a barrier to variant effect prediction, as observed in the structure-informed PLM study. When fine-tuning PLMs, monitor performance on validation sets to avoid degrading generalization.
Mismatched Evaluation Metrics
Different tasks require different evaluation metrics. Classification tasks benefit from AUPR and AUC, especially with imbalanced classes. Regression tasks require R-squared and RMSE. The crystallization benchmark reported AUPR, AUC, and F1, while the solubility study reported R-squared and RMSE. Choose metrics appropriate for your task and report them consistently.
Limitations and Interpretation Boundaries
PLMs Do Not Replace Experimental Validation
PLM predictions are computational hypotheses that require experimental validation. The FSFP study combined computational predictions with wet-lab experiments to engineer the Phi29 DNA polymerase, demonstrating that computational and experimental approaches are complementary. The AAV capsid engineering study combined experiments, deep sequencing, and large protein language models to gain insight on the impact of 7-mer insertions on the VR-VIII region, showcasing how AI can uncover structure-function rules governing the success of engineered AAV capsids.
Benchmark Performance Does Not Guarantee Task Performance
Published benchmarks provide guidance but do not guarantee performance on your specific task and dataset. The transfer learning analysis found that for the majority of tasks, performance does not scale with pretraining, suggesting that benchmark results may not generalize across tasks. Evaluate multiple PLMs on your own validation data before committing to a final model.
Domain-Specific Models May Outperform General Models
Domain-specific PLMs specialized for particular domains such as antibodies and T-cell receptors may outperform general models for those domains. A review in Allergology International discussed recent trends in multimodal approaches that integrate co-evolutionary information, structural information, and functional information, as well as domain-specific models. Consider whether a domain-specific model exists for your application area.
Safety and Regulatory Context
Data Sharing and Privacy
When working with protein sequence data, consider data sharing policies that may apply to your research. The NIH Genomic Data Sharing Policy provides guidance on sharing genomic data generated through NIH-funded research. If your work involves human sequences or clinical applications, ensure compliance with applicable data protection regulations.
Responsible Use of Generative Models
Generative PLMs can design novel protein sequences with potential dual-use concerns. The antimicrobial peptide study demonstrated generative design resulting in over 500 novel AMPs, highlighting both therapeutic potential and the need for responsible use. When using generative models, consider the potential applications of designed sequences and follow institutional guidelines for responsible research.
Reproducibility Standards
Following the FAIR Guiding Principles ensures that your PLM workflows are reproducible and reusable by other researchers. This includes documenting data sources, model versions, and analysis parameters. The principles emphasize findability, accessibility, interoperability, and reusability of data and workflows.
Professional Escalation Criteria
When to Seek Expert Assistance
Consider consulting with bioinformatics specialists or computational biologists when:
- Your task requires integrating PLM embeddings with structural data and you lack experience with structural bioinformatics tools
- You need to fine-tune a large PLM and are uncertain about hyperparameter choices or computational resource requirements
- Your results show unexpected patterns that may indicate data leakage, overfitting, or methodological errors
- You are applying PLMs to clinical or regulatory contexts where validation requirements are stringent
When to Question Model Outputs
Treat PLM outputs with caution when:
- Input sequences are highly divergent from known protein families
- Predictions conflict with established experimental evidence
- Performance on validation sets is substantially worse than published benchmarks
- The task requires precise quantitative predictions where small errors have significant consequences
Frequently Asked Questions
What is the difference between protein language models and traditional sequence alignment methods?
Protein language models learn statistical patterns from large collections of protein sequences during pre-training, producing embeddings that capture evolutionary, structural, and functional information. Traditional sequence alignment methods such as multiple sequence alignments extract evolutionary information by comparing related sequences within a protein family. According to a review in Current Opinion in Structural Biology, for many applications, MSA-free PLM-based predictions have become significantly more accurate than traditional approaches, and PLM-based methods tend to consume fewer computational resources than MSA-based solutions once pre-training is complete.
How do I choose between ESM2, ProtT5, and other protein language models?
Model choice depends on your task type, available computational resources, and published benchmark performance. For protein crystallization prediction, ESM2 embeddings with LightGBM classifiers outperformed other PLMs including Ankh, ProtT5-XL, ProstT5, xTrimoPGLM, and SaProt. For antimicrobial peptide detection, a pipeline integrating PLMs with machine learning achieved average precision exceeding 83 percent. Evaluate multiple models on your own validation data, as benchmark performance does not guarantee performance on your specific task.
Can protein language models predict protein structure from sequence?
Protein language models capture structural information implicitly through sequence patterns, but they are not structure prediction tools themselves. The study in Genes noted that large language models have exhibited promising outcomes for protein function prediction, but their focus primarily lies on protein sequences, disregarding the 3D structures of proteins. For structure prediction, dedicated tools such as AlphaFold are used. However, PLM embeddings can be combined with structural information to improve performance on tasks like solubility prediction, as demonstrated by the SeqStruct-XAttn model.
How much labeled data do I need to fine-tune a protein language model?
The FSFP study demonstrated that protein language models can be optimized under extreme data scarcity for fitness prediction using merely tens of labeled single-site mutants from the target protein. This approach combined meta-transfer learning, learning to rank, and parameter-efficient fine-tuning. If you have very limited labeled data, consider using PLM embeddings with a simple downstream classifier instead of fine-tuning the full model.
What are the computational requirements for using protein language models?
Computational requirements vary substantially by model size. ESM2 models are available in multiple sizes, with the crystallization benchmark evaluating models with 150 and 3000 million parameters. The transfer learning analysis found that for the majority of tasks, performance does not scale with pretraining, suggesting that smaller models may suffice for many applications. Consider using pre-computed embeddings or cloud-based services if local computational resources are limited.
How do I evaluate whether a protein language model is memorizing training data?
Pseudoperplexity can serve as a probe for sequence-level memorization. A study comparing ProtT5 pseudoperplexity on a pre-training proxy dataset against a post-training holdout of genuinely novel sequences found a statistically significant difference between seen and unseen sequences, though the memorization signal was modest. For practical purposes, validate PLM performance on sequences that are genuinely novel relative to training data to assess generalization.
Can protein language models be used for protein design and generation?
Yes, PLMs can generate novel protein sequences. The crystallization benchmark study fine-tuned ProtGPT2 to generate crystallizable proteins, identifying 5 novel proteins as potentially crystallizable through a filtration process. A study on sampling strategies found that approaches considering multiple mutations simultaneously significantly outperform single-mutant approaches by better capturing epistatic effects between residue pairs. Generative PLM outputs require experimental validation.
How do protein language models handle protein-protein interactions?
Standard PLMs encode single proteins, but the PLM-interact approach extends PLMs by jointly encoding protein pairs to learn their relationships, analogous to next-sentence prediction in natural language processing. This approach achieved state-of-the-art performance on a cross-species protein-protein interaction prediction benchmark and outperformed existing approaches in predicting virus-host interactions at the protein level.
Related Bioinformatics Guides
- De Novo Protein Design Using Computational Structures
- Alphafold Protein Ligand Docking: Structural Analysis and Computational Methodologies in Bioinformatics
- AI-Driven Protein Language Models for Predicting Viral Host Tropism and Zoonotic Potential
- Deep Learning-Driven Protein Language Models for Predicting Antigenic Drift in Influenza A Hemagglutinin
- Protein Language Models in Drug Discovery: Embeddings, Variant Effect Prediction, and Binder Prioritization
References and Further Reading
- EMBL-EBI Training. European Bioinformatics Institute.
- NCBI Data Resources. National Center for Biotechnology Information.
- Genomic Data Sharing Policy. National Institutes of Health.
- The FAIR Guiding Principles. Scientific Data.
- When Protein Structure Embedding Meets Large Language Models.. Genes, 2023.
- Protein Language Models and Machine Learning Facilitate the Identification of Antimicrobial Peptides.. International journal of molecular sciences, 2024.
- Benchmarking protein language models for protein crystallization.. Scientific reports, 2025.
- Decoding viral protein sequences by large language models.. Briefings in bioinformatics, 2026.
- Enhancing efficiency of protein language models with minimal wet-lab data through few-shot learning.. Nature communications, 2024.
- Integration of pre-trained protein language models into geometric deep learning networks.. Communications biology, 2023.
- PLM-interact: extending protein language models to predict protein-protein interactions.. Nature communications, 2025.
- Structure-Informed Protein Language Models are Robust Predictors for Variant Effects.. Research square, 2023.
- Pseudoperplexity Probes Memorization in Protein Language Models. 2026.
- Sequence-structure cross-attention model integrating ESM-2 embeddings and AlphaFold cues for accurate prediction of Escherichia coli protein solubility.. 2026.
- CMA-DTI: a cross-modal fusion and attentive interaction network for interpretable drug-target interaction prediction
- Viability of engineered AAVs via protein language models. 2026.
- Are protein language models the new universal key?. Current Opinion in Structural Biology, 2025.
- BepiPred-3.0: Improved B-cell epitope prediction using protein language models. bioRxiv, 2022.
- A Comprehensive Review of Protein Language Models. 2025.
- Predictive and therapeutic applications of protein language models.. Allergology International, 2025.
- Sampling Protein Language Models for Functional Protein Design. bioRxiv, 2025.
- Feature Reuse and Scaling: Understanding Transfer Learning with Protein Language Models. bioRxiv, 2024.
- A Fine-tuning Dataset and Benchmark for Large Language Models for Protein Understanding. Proceedings 2024 IEEE International Conference on Bioinformatics and Biomedicine Bibm 2024, 2024.
- PEER: A Comprehensive and Multi-Task Benchmark for Protein Sequence Understanding. Advances in Neural Information Processing Systems, 2022.
- DART-Eval: A Comprehensive DNA Language Model Evaluation Benchmark on Regulatory DNA. Advances in Neural Information Processing Systems, 2024.
- Free Energy Landscape and Markov State Model Analyses as Benchmarks for Molecular Dynamics Large Language Models of Protein-Ligand Interactions. Proceedings 27th International Symposium on Symbolic and Numeric Algorithms for Scientific Computing Synasc 2025, 2025.
This article is educational and does not replace validated analysis plans, institutional policy, clinical interpretation, or specialist review.